2021-037 Yan'an Pharmaceutical: Announcement of Resolutions of the Eighteenth Meeting of the Second Board of Directors
classification: Investor relations
Time:2021-11-19 14:51
1. Meeting and attendance
(1) The convening of the meeting
1. Meeting time: November 15, 2021
2. Meeting place: company meeting room
3. Meeting method: on-site and communication
4. Time and method of issuing notice of board meeting: in writing on November 10, 2021
5. Moderator of the meeting: Chairman Wang Xueliang
6. Participants in attendance at the meeting: Chairman Wang Xueliang
7. Explanation of the legality, compliance and constitutionality of the convening:
The convening and convening procedures of this meeting, the qualifications of attending the meeting and the qualifications of the convener, and the voting procedures of the meeting are in compliance with the "Company Law of the People's Republic of China", "Articles of Association" and relevant laws, regulations and regulations, and the resolutions made are legal and valid.
(2) Meeting attendance
7 directors should be present at the meeting, and 7 directors should be present and authorized to attend.
2. Review of the proposal
(1) Deliberated and approved the "Proposal on Nominating the Company's Core Employees"
1. The content of the proposal:
The report has been disclosed in the "Announcement on Publicizing the Proposed Core Employees and Asking for Comments" (Announcement No.: 2021-039) published on the Information Disclosure Platform of the National Small and Medium-sized Enterprise Share Transfer System (www.neeq.com.cn)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
Reason for objection/abstention: None
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(2) Deliberated and approved the "Proposal on the Company's 2021 Restricted Stock Incentive Plan (Draft)"
1. The content of the proposal:
The report has been disclosed in the "2021 Restricted Stock Incentive Plan (Draft)" (Announcement No.: 2021-040) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
Reason for objection/abstention: None
Chen Daofeng, the current independent director of the company, expressed an independent opinion in agreement with this proposal. (If any)
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(3) Deliberated and approved the "Proposal on Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Fully Manage Matters Related to the Restricted Stock Incentive Plan for 2021"
1. The content of the proposal:
In order to implement the company's equity incentive plan, in accordance with the "Articles of Association" and other relevant regulations, the company's board of directors has asked the shareholders meeting to authorize the board of directors to handle matters related to the restricted stock incentive plan in 2021.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
Reason for objection/abstention: None
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(4) Deliberated and approved the "Proposal on the List of Incentive Objects of the Company's 2021 Restricted Stock Incentive Plan"
1. The content of the proposal:
The report has been disclosed in the "List of Incentive Objects Granted by the Restricted Stock Incentive Plan for 2021" (Announcement No.: 2021-041) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
Reason for objection/abstention: None
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(5) Deliberated and approved the "Proposal on Formulating the Implementation Evaluation and Management Measures for the 2021 Restricted Stock Incentive Plan"
1. The content of the proposal:
The report has been disclosed in the "Administrative Measures for the Implementation Evaluation of Restricted Stock Incentive Plans for 2021" (Announcement No.: 2021-042) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
Reason for objection/abstention: None
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(6) Deliberated and approved the "Proposal on Proposal to Convene the Company's 2021 Third Extraordinary General Meeting of Shareholders"
1. The content of the proposal:
The report has been disclosed in the "Announcement on the Notice of Convening the Third Extraordinary General Meeting of Shareholders in 2021" (Announcement No.: 2021-043) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
Reason for objection/abstention: None
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
3. List of available documents
Resolutions of the eighteenth meeting of the second board of directors of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
November 16, 2021